Merck plans to conduct clinical trials of Multi-Valent HPV vaccine, single-dose regimen for GARDASIL9 Susmita Roy14 March 2024 3:09 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, at the EUROGIN 2024 HPV Congress, has announced plans to initiate clinical...
Merck concludes acquisition of Harpoon Therapeutics Ruchika Sharma13 March 2024 12:59 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has completed the acquisition of Harpoon Therapeutics, Inc. Harpoon is now a...
Germany Merck sees return to organic earnings growth in 2024 Ruchika Sharma7 March 2024 4:52 PM ISTFrankfurt: Merck KGaA forecast a return to modest operating earnings growth this year but only when adjusted for currency headwinds, citing a...
Merck gets positive EMA Committee opinion for Keytruda, chemotherapy combo for Resectable non-small cell lung cancer Ruchika Sharma26 Feb 2024 2:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency's Committee for Medicinal...
Merck application for Keytruda plus chemotherapy for Primary Advanced or Recurrent Endometrial Carcinoma accepted by USFDA for priority review Ruchika Sharma22 Feb 2024 12:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
Merck Animal Health to acquire Elanco Aqua Business for USD 1.3 billion Ruchika Sharma6 Feb 2024 4:00 PM ISTRahway: Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway,...
Merck seeks more deals to prepare for Keytruda revenue decline Ruchika Sharma4 Feb 2024 12:30 PM ISTMerck & Co on Thursday said it was in the market for deals of up to around $15 billion as it plans for a loss of revenue from its aging cancer...
Merck gets USFDA nod for Keytruda plus chemoradiotherapy for FIGO 2014 Stage III-IVA Cervical Cancer Ruchika Sharma13 Jan 2024 1:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA,...
Merck to acquire Harpoon Therapeutics for USD 680 million Ruchika Sharma10 Jan 2024 4:31 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, and Harpoon Therapeutics, Inc. have announced that the companies have...
Merck announces Phase 3 trial initiations for 4 investigational candidates from its hematology, oncology pipeline Ruchika Sharma6 Jan 2024 12:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the initiation of pivotal Phase 3 trials for four of its...
Merck seeks GLP-1 drugs with benefits beyond weight loss, says CEO Ruchika Sharma5 Jan 2024 3:36 PM ISTRahway: Merck & Co is seeking GLP-1 treatments with benefits beyond weight loss, CEO Robert Davis said on Thursday at a conference.Newer...
Merck gets European Commission nod for two new indications for Keytruda in gastrointestinal cancers Ruchika Sharma22 Dec 2023 11:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the European Commission (EC) has approved two new indications...
